Investor Overview We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Intersect ENT's financial performance into perspective. Financial Releases Jan 19, 2021 Summary ToggleIntersect ENT Announces CMS Approval of Coding Application for PROPEL® Sinus Implant Jan 12, 2021 Summary ToggleIntersect ENT Announces Preliminary Revenue for Fourth Quarter of 2020 View all financial releases » Events & Presentations More events are coming soon. View all events & presentations »